ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ФАРМСИНЕРГИЯ"
发明人:
Прадхан, Ирина Николаевна,Воробьев, Александр Николаевич
申请号：
EA201600291
公开号：
EA201600291A2
申请日:
2016.04.27
申请国别(地区):
EA
年份:
2016
代理人:
摘要：
the invention relates to medicine and the chemical and pharmaceutical industry and represents a solution for the temporary protection of bladder mucosa in various kinds of manipulation, in \u0443\u0440\u0435\u0442\u0440\u043e - \u0446\u0438\u0441\u0442\u043e\u0441\u043a\u043e\u043f\u0438\u0438, radiation therapy, in the treatment of \u0446\u0438\u0441\u0442\u0438\u0442\u043e\u0432 of varying etiology causing irritation of the bladder \u043f\u0443\u0437\u044b \u0440\u044f (chronic \u0446\u0438\u0441\u0442\u0438\u0442\u0435, \u043b\u0443\u0447\u0435\u0432\u043e\u043c \u0446\u0438\u0441\u0442\u0438\u0442\u0435, \u0438\u043d\u0442\u0435\u0440\u0441\u0442\u0438\u0446\u0438\u0430\u043b\u044c\u043d\u043e\u043c \u0446\u0438\u0441\u0442\u0438\u0442\u0435) and so on.the technical result of the invention is the creation of a new water compositionswhich has increased the protective effect on the cells \u0443\u0440\u043e\u0442\u0435\u043b\u0438\u044f after \u043e\u043a\u0438\u0441\u043b\u0438\u0442\u0435\u043b\u044c\u043d\u043e\u0433\u043e stress by incorporating in the composition \u043c\u0430\u043d\u043d\u0438\u0442\u0430 or \u0441\u043e\u0440\u0431\u0438\u0442\u0430 \u043f\u043e\u0432\u044b\u0448 \u0435\u043d\u043d\u044b\u043c \u0430\u043d\u0442\u0438\u043c\u0438\u043a\u0440\u043e\u0431\u043d\u044b\u043c act and the protection of \u0443\u0440\u043e\u0442\u0435\u043b\u0438\u044f by incorporating zinc chloride controlled viscosity through the incorporation of \u043c\u0430\u043d\u043d\u0438\u0442\u0430 or \u0441\u043e\u0440\u0431\u0438\u0442\u0430 and zinc chloride.the technical result is achieved by the use of the compositions for \u0438\u043d\u0441\u0442\u0438\u043b\u043b\u044f\u0446\u0438\u0438 in bladder based on hyaluronic acid and chondroitin with \u0443\u043b\u044c\u0444\u0430\u0442\u0430, which differed in that additionally contains mannitol or sorbitol in proportion to the amount of hyaluronic acid and chondroitin sulfate, equal 0014 - 4.2 in the next the content of com
